6-KThe Wire
Alpha Tau Medical Ltd. files 6-K
Filed Jan 6, 2026 · 7mo ago · Accession 0001213900-26-001598
Plain English
Alpha Tau Medical Ltd. announced positive results from its Pancreatic Cancer Alpha DaRT® Study in two upcoming presentations at the ASCO GI 2026 Symposium, showcasing immune-preservation and high disease control.
Filing details
- Company
- Alpha Tau Medical Ltd.
- Ticker
- DRTS
- CIK
- 1871321
- Form type
- 6-K
- Filing date
- Jan 6, 2026
- Report date
- Jan 6, 2026
- Document
- ea027162401-6k_alpha.htm
- Size
- 26 KB